Horiko Capital Management Reduces McKesson Holdings

Institutional investor trims stake in pharmaceutical distributor

Mar. 16, 2026 at 10:52am

Got story updates? Submit your updates here. ›

Horiko Capital Management LLC, an institutional investor, reduced its position in shares of McKesson Corporation (NYSE:MCK) by 2.4% during the 3rd quarter, according to a recent SEC filing. The firm now owns 46,281 shares of the company's stock, valued at $35.64 million, making it one of Horiko's top holdings.

Why it matters

McKesson is a major pharmaceutical distributor and healthcare services company, so changes in institutional ownership can provide insights into market sentiment around the stock. Horiko's reduction, while relatively small, could signal broader concerns about the company's performance or outlook.

The details

According to the filing, Horiko Capital Management sold 1,122 shares of McKesson during the 3rd quarter, reducing its total position to 46,281 shares. The stock now makes up approximately 8.4% of Horiko's overall portfolio, making it the firm's 6th largest holding.

  • Horiko Capital Management reduced its McKesson holdings during the 3rd quarter of 2026.

The players

Horiko Capital Management LLC

An institutional investment firm that owns a sizable stake in pharmaceutical distributor McKesson Corporation.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products, and healthcare technology solutions.

Got photos? Submit your photos here. ›

The takeaway

Horiko Capital Management's reduction in its McKesson holdings, while relatively small, could signal broader concerns about the company's performance or outlook among some institutional investors. However, McKesson remains a major player in the pharmaceutical distribution and healthcare services space.